MiR-9 expression in ASCI tissue was lower than that in normal spinal cord tissue.
10">The reliability of our results is secured by in vitro experiment and rat model.
15">MCPIP1 mRNA could be a negative target of miR-9 during ASCI.
MiR-9 as an excellent therapeutic target for ASCI patients is well-elaborated.
This topic contributes to early identification of intervention targets for ASCI.